BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 23631806)

  • 1. Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer.
    Shen SN; Wang LF; Jia YF; Hao YQ; Zhang L; Wang H
    Diagn Pathol; 2013 Apr; 8():69. PubMed ID: 23631806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of microRNA-145 is associated with aggressive progression and poor prognosis in human cervical cancer.
    Wang Q; Qin J; Chen A; Zhou J; Liu J; Cheng J; Qiu J; Zhang J
    Tumour Biol; 2015 May; 36(5):3703-8. PubMed ID: 25560490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
    Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
    BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M; Shen D; Wang W; Xian J
    Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of microRNA-126 is associated with poor prognosis in patients with cervical cancer.
    Yang Y; Song KL; Chang H; Chen L
    Diagn Pathol; 2014 Dec; 9():220. PubMed ID: 25551621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down regulation of miR-143 is related with tumor size, lymph node metastasis and HPV16 infection in cervical squamous cancer.
    Chen Y; Ma C; Zhang W; Chen Z; Ma L
    Diagn Pathol; 2014 Apr; 9():88. PubMed ID: 24774218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular identification of miR-145 and miR-9 expression level as prognostic biomarkers for early-stage cervical cancer detection.
    Azizmohammadi S; Safari A; Azizmohammadi S; Kaghazian M; Sadrkhanlo M; Yahaghi E; Farshgar R; Seifoleslami M
    QJM; 2017 Jan; 110(1):11-15. PubMed ID: 27345415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of miRNA-21 and their potential as biomarkers for the diagnosis of cervical cancer.
    Han Y; Xu GX; Lu H; Yu DH; Ren Y; Wang L; Huang XH; Hou WJ; Wei ZH; Chen YP; Cao YG; Zhang R
    Int J Clin Exp Pathol; 2015; 8(6):7131-9. PubMed ID: 26261606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
    Li M; Li BY; Xia H; Jiang LL
    Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance and functions of microRNA-93/CDKN1A axis in human cervical cancer.
    Zhang X; Li F; Zhu L
    Life Sci; 2018 Sep; 209():242-248. PubMed ID: 30098344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis.
    Zhang XW; Liu N; Chen S; Wang Y; Zhang ZX; Sun YY; Qiu GB; Fu WN
    Diagn Pathol; 2015 Apr; 10():22. PubMed ID: 25879432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulated microRNA-155 expression is associated with poor prognosis in cervical cancer patients.
    Fang H; Shuang D; Yi Z; Sheng H; Liu Y
    Biomed Pharmacother; 2016 Oct; 83():64-69. PubMed ID: 27470551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma.
    Li BK; Huang PZ; Qiu JL; Liao YD; Hong J; Yuan YF
    Diagn Pathol; 2014 Dec; 9():226. PubMed ID: 25466449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
    Cai L; Cai X
    Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
    Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulated miR-22 as predictive biomarkers for prognosis of epithelial ovarian cancer.
    Wan WN; Zhang YQ; Wang XM; Liu YJ; Zhang YX; Que YH; Zhao WJ; Li P
    Diagn Pathol; 2014 Sep; 9():178. PubMed ID: 25257702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL; Chen LM; Wang WM; Zhang LM
    Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma.
    Su ZX; Zhao J; Rong ZH; Geng WM; Wu YG; Qin CK
    Diagn Pathol; 2014 Mar; 9():47. PubMed ID: 24593846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of microRNA-372 upregulation with poor prognosis in human glioma.
    Li G; Zhang Z; Tu Y; Jin T; Liang H; Cui G; He S; Gao G
    Diagn Pathol; 2013 Jan; 8():1. PubMed ID: 23298385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancer.
    Jiang W; Pan JJ; Deng YH; Liang MR; Yao LH
    J Gynecol Oncol; 2017 Nov; 28(6):e75. PubMed ID: 29027393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.